TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01865084

A Study of Tadalafil for Duchenne Muscular Dystrophy

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.
“The study is being terminated for lack of efficacy”

The sponsor’s own words in the registry.

Life of this trial

201320142015201620172018Registered2013-05-24Started2013-09Primary completion2015-12Stopped2016-03Results posted2017-03-01

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Eli Lilly and Company
Sponsor type
Industry
Conditions
Muscular Dystrophy, Duchenne
Interventions
Tadalafil; Placebo
Participants
331
Sites
62
Countries
Argentina, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Puerto Rico, Russia, South Korea, Spain and more

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.